Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Aprea Therapeutics Inc.
APRE
$
5.05
14%
Tue February 23rd, 2021
17:00
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Rating
Analysis
All You Need to Know About Aprea Therapeutics, Inc. (APRE) Rating Upgrade to Buy
Zacks
Tue February 16th, 2021
16:36
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
Guide
Assessing Aprea Therapeutics
Seeking Alpha
Fri January 22nd, 2021
17:00
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
What Makes Aprea Therapeutics, Inc. (APRE) a New Buy Stock
Zacks
Tue January 19th, 2021
21:43
Analysis
Aprea Therapeutics (APRE) Presents at J.P. Morgan Healthcare Conference 2021 - Slideshow
Seeking Alpha
Tue December 29th, 2020
15:32
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
Aprea (APRE) Plunges as Late-Stage MDS Study Fails to Meet Goal
Zacks
Tue July 21st, 2020
19:48
Analysis
Aprea Therapeutics Cancer Therapy Platform Is Promising
Seeking Alpha
Wed July 1st, 2020
14:32
Analysis
How Aprea Therapeutics (APRE) Stock Stands Out in a Strong Industry
Zacks
Fri June 12th, 2020
02:44
Analysis
Aprea Therapeutics (APRE) in Focus: Stock Moves 5.8% Higher
Zacks
Wed June 10th, 2020
13:39
Analysis
Is Aprea Therapeutics Stock a Buy?
The Motley Fool
+ 16 more
